Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT

0.21 Down 0.00(1.82%) May 17, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 42   53   39   49  
Cost of Revenue191  513  988  208  
Gross Profit (149) (460) (949) (159)
Operating Expenses
Research Development2,336  3,750  2,357  1,736  
Selling General and Administrative2,077  3,785  1,659  1,738  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (4,562) (7,995) (4,965) (3,633)
Income from Continuing Operations
Total Other Income/Expenses Net956  2,541  (1,615)634  
Earnings Before Interest And Taxes(3,606)(5,454)(6,580)(2,999)
Interest Expense5  5  7  1  
Income Before Tax(3,611)(5,459)(6,587)(3,000)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,611)(5,459)(6,587)(3,000)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,611) (5,459) (6,587) (3,000)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,611) (5,459) (6,587) (3,000)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.